Search Results - "Leimig, T."

Refine Results
  1. 1

    Ocorrência dos Linfomas Malignos não Hodgkin Segundo a Classificação de Lennert (Kiel) em São Paulo — Brasil by Machado, J. C., Leimig, T., Rodrigues, M. L. Sales

    Published in Revista Brasileira de Cancerologia (11-08-2023)
    “…Os A. A. relatam a distribuição dos subtipos de L. M. não Hodgkin em 71 casos do Hospital A. C. Camargo de São Paulo (Brasil), segundo a classificação de K…”
    Get full text
    Journal Article
  2. 2

    A large-scale method for the selective depletion of alpha beta T lymphocytes from PBSC for allogeneic transplantation by Chaleff, S, Otto, M, Barfield, Rc, Leimig, T, Iyengar, R, Martin, J, Holiday, M, Houston, J, Geiger, T, Huppert, V, Handgretinger, R

    Published in Cytotherapy (Oxford, England) (01-01-2007)
    “…Background We sought to develop a method for the clinical large-scale depletion of alpha beta T lymphocytes from mobilized peripheral stem cells, which would…”
    Get full text
    Journal Article
  3. 3

    Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells by GORDON, P. R, LEIMIG, T, BABARIN-DORNER, A, HOUSTON, J, HOLLADAY, M, MUELLER, I, GEIGER, T, HANDGRETINGER, R

    Published in Bone marrow transplantation (Basingstoke) (01-01-2003)
    “…We have evaluated the feasibility of large-scale isolation of CD133+ progenitors from healthy mobilized adult donors for potential clinical use in autologous…”
    Get full text
    Journal Article
  4. 4

    A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation by Chaleff, S, Otto, M, Barfield, R.C, Leimig, T, Iyengar, R, Martin, J, Holiday, M, Houston, J, Geiger, T, Huppert, V, Handgretinger, R

    Published in Cytotherapy (Oxford, England) (2007)
    “…Background We sought to develop a method for the clinical large-scale depletion of αβ T lymphocytes from mobilized peripheral stem cells, which would allow the…”
    Get full text
    Journal Article
  5. 5

    Purification of human natural killer cells using a clinical-scale immunomagnetic method by Iyengar, R., Handgretinger, R., Babarin-Dorner, A., Leimig, T., Otto, M., Geiger, T.L., Holladay, M.S., Houston, J., Leung, W.

    Published in Cytotherapy (Oxford, England) (01-12-2003)
    “…Infection, graft failure, disease relapse, and GvHD are significant adverse events associated with allogeneic BMT. Although donor leukocyte infusion has been…”
    Get full text
    Journal Article
  6. 6

    A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation by Barfield, R.C., Otto, M., Houston, J., Holladay, M., Geiger, T., Martin, J., Leimig, T., Gordon, P., Chen, X., Handgretinger, R.

    Published in Cytotherapy (Oxford, England) (01-01-2004)
    “…The presence of Tand B cells in allogeneic grafts contributes to GvHD and to EBV-associated lymphoproliferative disease (LPD). Depletion of T and B cells from…”
    Get full text
    Journal Article
  7. 7

    Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells by Kuçi, S., Kuçi, Z., Schmid, S., Seitz, G., Müller, I., Dufke, A., Leimig, T., Murti, G., Jurecic, R., Schumm, M., Lang, P., Bruchelt, G., Bader, P., Klingebiel, T., Niethammer, D., Handgretinger, R.

    Published in Cell proliferation (01-02-2008)
    “… Objectives: To generate non‐haematopoietic tissues from mobilized haematopoietic CD133+ stem cells. Materials and methods: Mobilized peripheral blood CD133+…”
    Get full text
    Journal Article
  8. 8

    A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells by GORDON, P. R, LEIMIG, T, MUELLER, I, BABARIN-DORNER, A, HOLLADAY, M. A, HOUSTON, J, KERST, G, GEIGER, T, HANDGRETINGER, R

    Published in Bone marrow transplantation (Basingstoke) (01-07-2002)
    “…We have investigated the feasibility and efficacy of large-scale T cell depletion from granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil by SANDLUND, J. T, FONSECA, T, CHEN, G, PUI, C.-H, HEIM, M, PEDROSA, F, LEIMIG, T, VERISSIMO, L, RIBEIRO, R, LIRA, V, BERARD, C. W, SIXBEY, J, CRIST, W. M, MAO, L

    Published in Leukemia (01-05-1997)
    “…The purpose of this paper was to define the histologic distribution, clinical features, and treatment response of childhood non-Hodgkin lymphoma (NHL) in…”
    Get full text
    Journal Article
  12. 12

    Immunomodulatory effects of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2 by Leimig, T, Foreman, N, Rill, D, Coze, C, Holladay, M, Brenner, M

    Published in Cancer gene therapy (01-12-1994)
    “…We have investigated whether retroviral mediated transfer of the IL-2 gene renders human neuroblastoma cells immunogenic, justifying their use in a clinical…”
    Get more information
    Journal Article
  13. 13

    Biology and Plasticity of CD133+ Hematopoietic Stem Cells by HANDGRETINGER, RUPERT, GORDON, PAUL R., LEIMIG, THASIA, CHEN, XIAOHUA, BÜHRING, HANS-JÖRG, NIETHAMMER, DIETRICH, KUÇI, SELIM

    Published in Annals of the New York Academy of Sciences (01-05-2003)
    “…: AC133 (CD133) is a highly conserved antigen expressed on hematopoietic stem cells with unknown function. In order to further characterize CD133+ progenitor…”
    Get full text
    Journal Article
  14. 14

    Combination Immunotherapy with Clinical-Scale Enriched Human gamma delta T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma by Otto, Mario, Barfield, Raymond C, Martin, William J, Iyengar, Rekha, Leung, Wing, Leimig, Thasia, Chaleff, Stanley, Gillies, Stephen D, Handgretinger, Rupert

    Published in Clinical cancer research (01-12-2005)
    “…PURPOSE: To evaluate a combined cellular and humoral immunotherapy regimen in a mouse model of disseminated human neuroblastoma. We tested combinations of…”
    Get full text
    Journal Article
  15. 15

    Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells by Leimig, Thasia, Mann, Linda, Martin, Maria del Pilar, Bonten, Erik, Persons, Derek, Knowles, James, Allay, James A., Cunningham, John, Nienhuis, Arthur W., Smeyne, Richard, d'Azzo, Alessandra

    Published in Blood (01-05-2002)
    “…Protective protein/cathepsin A (PPCA), a lysosomal carboxypeptidase, is deficient in the neurodegenerative lysosomal disorder galactosialidosis (GS). PPCA−/−…”
    Get full text
    Journal Article
  16. 16

    Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method by WING LEUNG, IYENGAR, Rekha, LEIMIG, Thasia, HOLLADAY, Marti S, HOUSTON, James, HANDGRETINGER, Rupert

    Published in Cancer Immunology, Immunotherapy (01-04-2005)
    “…Infection, disease relapse, graft failure, and graft-versus-host disease (GVHD) are significant adverse events associated with allogeneic bone marrow…”
    Get full text
    Journal Article
  17. 17

    Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma by Bowman, L C, Grossmann, M, Rill, D, Brown, M, Zhong, W Y, Alexander, B, Leimig, T, Coustan-Smith, E, Campana, D, Jenkins, J, Woods, D, Brenner, M

    Published in Human gene therapy (10-06-1998)
    “…Tumor cells that have been genetically modified to express immunostimulatory genes will induce effective antitumor responses in a range of syngeneic animal…”
    Get more information
    Journal Article
  18. 18

    A large-scale method for the selective depletion of T lymphocytes from PBSC for allogeneic transplantation by Chaleff, S, Otto, M, Barfield, Rc, Leimig, T, Iyengar, R, Martin, J, Holiday, M, Houston, J, Geiger, T, Huppert, V, Handgretinger, R

    Published in Cytotherapy (Oxford, England) (2007)
    “…Background We sought to develop a method for the clinical large-scale depletion of T lymphocytes from mobilized peripheral stem cells, which would allow the…”
    Get full text
    Journal Article
  19. 19

    Retrovirus-mediated gene transfer of the cytokine genes interleukin-1beta and tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties by Coze, C, Leimig, T, Jimeno, M T, Mannoni, P

    Published in European cytokine network (Montrouge) (01-03-2001)
    “…We have investigated the value of a gene therapy approach for neuroblastoma (NB), based on retroviral transduction of the IL-1beta or TNF-alpha cytokine genes…”
    Get more information
    Journal Article
  20. 20

    A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation by Chaleff, S, Otto, M, Barfield, R C, Leimig, T, Iyengar, R, Martin, J, Holiday, M, Houston, J, Geiger, T, Huppert, V, Handgretinger, R

    Published in Cytotherapy (Oxford, England) (2007)
    “…We sought to develop a method for the clinical large-scale depletion of alphabeta T lymphocytes from mobilized peripheral stem cells, which would allow the…”
    Get full text
    Journal Article